Breast cancer is a group of related diseases that can behave differently depending on their biology. This is why doctors often recommend a breast receptor study after abreast cancer diagnosis. This test helps to reveal important information about the cancer, guiding doctors on the best treatment options for each individual.
What is a breast receptor study?
This test looks for special proteins called receptors on the surface of breast cancer cells. The three main ones are:
1. Estrogen receptors (ER) – These show if the cancer uses estrogen to grow.
2. Progesterone receptors (PR) – These show if the cancer uses progesteroneto grow.
3. HER2 receptors – These show if the cancer has higher levels of a proteincalled HER2, which can cause the cancer to grow faster.
By checking for these receptors, doctors can better understand what is causing the cancer to grow. For example, if a cancer is ER or PR positive, it means the cancer uses either the hormone estrogen or progesterone to grow. In this case, the doctor may recommend a treatment called hormone therapy to block those hormones and slow the cancer. If it is HER2 positive, it means there is a high amount of the protein HER2 on the cancer cells. The doctor may then recommend special medicine to find the HER2 protein directly and block it, this is called targeted therapy. Without this test, doctors would have less precise information and their prescribed treatment might not be as effective.
Why is it important?
Receptor studies may be thought of as a compass which points doctors in the right direction for treatment. The results help ensure that patients receive the medicines that are most likely to work for their specific type of breast cancer, improving outcomes and saving lives.
NHF support: Making it more affordable
At the National Health Fund (NHF), we know that medical costs can place a heavy burden on families. That’s why we have increased our NHFCard subsidy for breast receptor studies from $4,800 to $12,500 accessible at the University Hospital of the West Indies Pathology Lab. This means more Jamaicans can access this vital test without as much financial worry.
The increase reflects our continued commitment to supporting persons living with cancer, and ensuring that treatment decisions are based on the best possible information.
Early detection is still key
While the receptor study is vital after diagnosis, the first step is getting screened. Breast cancer that is found early is often easier to treat and gives the best chance for recovery. Women are encouraged to do regular self-checks, attend screening appointments and talk with their doctor if they notice any changes. Although not as common, men can also be affected by breast cancer, so this applies to them too.
Every person’s breast cancer journey is unique, but no one should walk it alone. With the right tests, the right treatment and the right support, there is hope. NHF is herefor you to lighten the load, because your health matters.
Get screened. Get tested. Get support. Together, we can beat breast cancer.
